| 12336980 |
Dosing regimen for a selective S1P1 receptor agonist |
Matthias Hoch, Andreas Krause |
2025-06-24 |
| 11834443 |
Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol |
Cyrille Lescop, Andreas Krause |
2023-12-05 |
| 11771683 |
Dosing regimen for a selective S1P1 receptor agonist |
Matthias Hoch, Andreas Krause |
2023-10-03 |
| 11390615 |
Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenox |
Cyrille Lescop, Andreas Krause |
2022-07-19 |
| 10857134 |
Dosing regimen for a selective S1P1 receptor agonist |
Matthias Hoch, Andreas Krause |
2020-12-08 |
| 10836754 |
Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol |
Cyrille Lescop, Andreas Krause |
2020-11-17 |
| 10660880 |
Dosing regimen for a selective S1P1 agonist |
Patrick Brossard, Oliver Nayler, Michael Scherz, Beat Steiner |
2020-05-26 |
| 10251867 |
Dosing regimen for a selective S1P1 receptor agonist |
Patrick Brossard, Oliver Nayler, Michael Scherz, Beat Steiner |
2019-04-09 |
| 10220023 |
Dosing regimen for a selective S1P1 receptor agonist |
Matthias Hoch, Andreas Krause |
2019-03-05 |
| 8785484 |
Dosing regimen for a selective S1P1 receptor agonist |
Patrick Brossard, Oliver Nayler, Michael Scherz, Beat Steiner |
2014-07-22 |